CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 79 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2015. The put-call ratio across all filers is 4.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $3,893,000 | +26.2% | 34,880 | +13.0% | 0.25% | +29.2% |
Q1 2017 | $3,086,000 | +17.9% | 30,855 | +26.7% | 0.20% | +16.1% |
Q4 2016 | $2,618,000 | -7.6% | 24,360 | +6.4% | 0.17% | -8.7% |
Q3 2016 | $2,834,000 | +27.2% | 22,901 | +9.3% | 0.18% | +8.9% |
Q2 2016 | $2,228,000 | +87.4% | 20,960 | +101.5% | 0.17% | +65.7% |
Q1 2016 | $1,189,000 | +6.2% | 10,400 | +32.1% | 0.10% | +9.7% |
Q4 2015 | $1,120,000 | -2.4% | 7,870 | -38.3% | 0.09% | -4.1% |
Q3 2015 | $1,148,000 | -23.9% | 12,750 | -2.7% | 0.10% | -13.4% |
Q2 2015 | $1,508,000 | +16.8% | 13,100 | -3.3% | 0.11% | +5.7% |
Q1 2015 | $1,291,000 | – | 13,550 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
Kylin Management | 188,226 | $21,676,000 | 2.36% |
Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |